Cookie Settings
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Other cookies are those that are being identified and have not been classified into any category as yet.

No cookies to display.

AGM Trading Update

16 June, 2020

At the Annual General Meeting of the Company to be held this morning, Martyn Ratcliffe, Executive Chairman, will provide the following update on trading.

“The Board is pleased to reaffirm that the performance of the Group in the year to date has been strong, despite the challenges posed by the Covid-19 pandemic. As a result, it is anticipated that Group adjusted operating profit for the first half of 2020 will be approximately 50% higher than reported in the same period of the prior year. Gross cash at 29 May 2020 was £21.6 million with net funds of £4.1 million.

This resilient performance has been achieved through a combination of organic growth in the Group’s services operations and the contribution from the restructured Frontier Smart Technologies business, acquired in 2019.

In terms of the Group’s services businesses, both the R&D Consultancy and Regulatory & Compliance Divisions have recorded revenue growth and increased profit contribution. While some business sectors have understandably been impacted by Covid-19, this has been more than offset by demand in other areas, with the Medical sector and the US regulatory operations performing particularly well compared to prior year.

As anticipated, revenue from the Frontier business has been impacted by the market contraction related to the pandemic, although we believe that the business’ substantial market share (estimated at 70-80%) has been maintained and that its second half revenue will begin to recover as retail outlets across Europe reopen. Furthermore, it is particularly pleasing to report that even at this lower revenue, Frontier has traded profitably, confirming the success of the rapid post-acquisition integration programme implemented before the outbreak of Covid-19 and providing confidence in the future potential of the business.

In summary, while the future global economic impact resulting from the pandemic remains unclear and the Board therefore remains cautious, the strong first half performance provides an excellent platform for the year as a whole. This enables the Group to continue to invest in future organic growth and explore further acquisition opportunities.”

- End -

Science Group plc

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Archer, Finance Director

www.sciencegroup.com

Panmure Gordon

Nominated Adviser: Dominic Morley, Alina Vaskina

Tel: +44 (0) 20 7886 2500

Corporate Broking: Erik Anderson

MHP Communications (PR Advisor to Science Group)

Reg Hoare, James Bavister, Pete Lambie Tel: +44 (0) 20 3128 8100

sciencegroup@mhpc.com

Note: This announcement contains inside information which is disclosed in accordance with the Market
Abuse Regulation (No 596/2014).

Haven't found what you were looking for?

Investor news

Read our investor news and announcements

Financial reports

View our financial reports and presentations